Gina Melchner supports Theragenix Ltd as an NLC Venture Partner, thereby providing the link between the venture and NLC’s experience and services.
Gina is responsible for multiple NLC Medtech and Biotech ventures and also leads the Medtech Domain within NLC’s Venture Creation engine. Before joining NLC in February 2020, Gina worked at Biogeneration Ventures in the Netherlands and at Oliver Wyman in Germany. Her academic background includes a Masters degree in Biotechnology from ETH Zurich.
